335 related articles for article (PubMed ID: 21880048)
1. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
Arndt PA; Leger RM; Garratty G
Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
[TBL] [Abstract][Full Text] [Related]
2. Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies.
Arndt PA; Leger RM; Garratty G
Transfusion; 2009 Feb; 49(2):235-42. PubMed ID: 18980619
[TBL] [Abstract][Full Text] [Related]
3. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.
Garratty G; Postoway N; Schwellenbach J; McMahill PC
Transfusion; 1991 Feb; 31(2):176-9. PubMed ID: 1825363
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.
Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H
Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244
[TBL] [Abstract][Full Text] [Related]
5. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.
Arndt PA; Leger RM; Garratty G
Transfusion; 1999; 39(11-12):1239-46. PubMed ID: 10604252
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced immune hemolytic anemia.
Garratty G
Hematology Am Soc Hematol Educ Program; 2009; ():73-9. PubMed ID: 20008184
[TBL] [Abstract][Full Text] [Related]
7. Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
Nguyen TN; Maenulein E; Fihman V; Vinatier I; Moh Klaren J
Transfusion; 2021 May; 61(5):1609-1616. PubMed ID: 33686704
[TBL] [Abstract][Full Text] [Related]
8. Immune hemolytic anemia caused by drugs.
Garratty G
Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
[TBL] [Abstract][Full Text] [Related]
9. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
[TBL] [Abstract][Full Text] [Related]
10. The first case of drug-induced immune hemolytic anemia due to hydrocortisone.
Martinengo M; Ardenghi DF; Tripodi G; Reali G
Transfusion; 2008 Sep; 48(9):1925-9. PubMed ID: 18565121
[TBL] [Abstract][Full Text] [Related]
11. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced immune hemolytic anemia: the last 30 years of changes.
Arndt PA
Immunohematology; 2014; 30(2):44-54. PubMed ID: 25247622
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
[TBL] [Abstract][Full Text] [Related]
14. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.
Johnson ST; Fueger JT; Gottschall JL
Transfusion; 2007 Apr; 47(4):697-702. PubMed ID: 17381629
[TBL] [Abstract][Full Text] [Related]
15. Ceftriaxone-induced immune hemolytic anemia.
Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
[TBL] [Abstract][Full Text] [Related]
16. Piperacillin-induced immune hemolysis: new cases and a concise review of the literature.
Mayer B; Yürek S; Salama A
Transfusion; 2010 May; 50(5):1135-8. PubMed ID: 20051057
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced immune hemolytic anemia investigation: Comparison between tube test and microcolumn agglutination (gel test) for the detection of drug-dependent antibodies in the presence of soluble drug.
Nguyen TN; Fihman V; Maenulein E; Vinatier I; Klaren JM
Transfus Clin Biol; 2020 Aug; 27(3):133-138. PubMed ID: 32561329
[TBL] [Abstract][Full Text] [Related]
18. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
Dinesh D; Dugan N; Carter J
Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
[TBL] [Abstract][Full Text] [Related]
19. How we investigate drug-induced immune hemolytic anemia.
Leger RM; Arndt PA; Garratty G
Immunohematology; 2014; 30(2):85-94. PubMed ID: 25247618
[TBL] [Abstract][Full Text] [Related]
20. Transfusion therapy in autoimmune hemolytic anemia.
Jefferies LC
Hematol Oncol Clin North Am; 1994 Dec; 8(6):1087-104. PubMed ID: 7860438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
